MP43-05 THE LANDSCAPE OF CLINICALLY ACTIONABLE GENOMIC ALTERATIONS IN PATIENTS WITH BACILLE CALMETTE-GUERIN (BCG) UNRESPONSIVE BLADDER CANCER: TOWARDS TARGETED THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.